Andean Precious Metals Q4 2023 Earnings Report C$1.26 -0.06 (-4.55%) (As of 12/17/2024 05:32 PM ET) Earnings HistoryForecast Andean Precious Metals EPS ResultsActual EPSC$0.29Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAndean Precious Metals Revenue ResultsActual Revenue$66.47 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAndean Precious Metals Announcement DetailsQuarterQ4 2023Date3/27/2024TimeN/AConference Call ResourcesAPM Earnings History Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Andean Precious Metals Earnings HeadlinesReturns On Capital Signal Tricky Times Ahead For Andean Precious Metals (CVE:APM)December 11, 2024 | finance.yahoo.comAndean Precious Metals: Stocks Overvalued by Analyst Consensus on TSX-V (APM)October 26, 2024 | theglobeandmail.comThis Crypto Is Set to Explode in DecemberDiscover our #1 crypto for the Trump Presidency Bull Run now! (Available for a Short Time) We highly recommend this hot altcoin before prices get too high December 18, 2024 | Crypto 101 Media (Ad)A&W Revenue, Bombardier, Blackrock at 52-Week Highs on NewsOctober 15, 2024 | baystreet.caMonday’s Insider Report: Billionaire Eric Sprott is buying two penny stocks with massive returns in 2024October 7, 2024 | theglobeandmail.comAndean Precious Metals Corp. (ANPMF)August 18, 2024 | finance.yahoo.comSee More Andean Precious Metals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Andean Precious Metals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Andean Precious Metals and other key companies, straight to your email. Email Address About Andean Precious MetalsAptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.View Andean Precious Metals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Upcoming Earnings Cintas (12/19/2024) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
